Viking Therapeutics, Inc VKTX
$33.51
+1.73%
at last close
Financials (TTM)
- Revenue
- —
- Net Income
- $-534,796,000
- Net Margin
- —
- Return on Equity
- -130.98%
- Debt-to-Equity
- —
- P/E Ratio
- —
- Price / Book
- 9.57
- Price / Sales
- —
Over the trailing twelve months, Viking Therapeutics, Inc generated revenue of — and net income of $-534,796,000.
Key Stats
- Last Close
- $33.51
- Market Cap
- $3.91 billion
- 52-Week Range
- $22.96 – $43.15
- Average Volume
- 2.50 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.